WHO Orders Investigation Of 4 Cough Syrup Brands Linked To 66 Deaths In Gambia

WHO Orders Investigation Of 4 Cough Syrup Brands Linked To 66 Deaths In Gambia

World Health Organisation (WHO), has issued alert on four cough and cold syrup brands that were produced by an India’s Pharmaceutical company warning that they might be linked to the death of 66 children in Gambia.

“WHO has today issued a medical product alert for four contaminated medicines identified in Gambia that have been potentially linked with acute kidney injuries and 66 deaths among children,” the global health body said on its verified twitter handle.

Join our WhatsApp Channel

Director General of the World Health Agency, Tedros Ghebreyesus, speaking on Wednesday identified the pharmaceutical company as Haryana-based Maiden Pharmaceuticals Limited

The Gambia’s Health Ministry asked hospitals last month to stop using the syrup paracetamol, pending the outcome of an investigation, after at least 28 children died of kidney failure.

The global Health agency boss also said “the loss of these young lives is beyond heartbreaking for their families.”

WHO said the drugs are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff baby syrup and Magrip N Cold syrup.

The health body said analysis from the laboratory showed that the four drugs contained unacceptable amount of “Diethylene Glycol and Ethylene Glycol” which when consumed could cause harm to the kidney.

WHO appealed to government of other countries to recall the drugs from their markets.

He added that even though the drugs were confirmed to have only been supplied to the Gambia there are fear that they might have been illegally shipped to other countries.

“While the contaminated products have so far only been detected in The Gambia, they may have been distributed to other countries. WHO recommends that all countries detect and remove these products from circulation to prevent further harm to patients,” the health body said.

Who also said it is working with the Indian drug authority and a pharmaceutical company to carry out more investigations.

John Adoyi, PBA Journalism Mentee
+ posts

Featured Stories

Latest from Africa

Kenya to Begin Administering HIV Prevention Drug

Kenya will begin rolling out a new HIV-prevention drug in March, in what health officials have described as a major step forward in the fight against the virus. The drug, lenacapavir, is taken just twice a year and has been shown in

Gabon Suspends Social Media Amid Rising Unrest

Gabon’s media regulator has ordered the suspension of social media platforms “until further notice,” citing content that it says is fuelling division and unrest in the country. The High Authority for Communication (HAC) announced the move on Tuesday. Spokesman Jean-Claude Mendome said

Tinubu Urges Release of South Sudan Vice-President

President Bola Tinubu has called for the immediate and unconditional release of South Sudan’s First Vice-President, Riek Machar, as part of efforts to revive the country’s stalled peace process. In a message delivered by Vice-President Kashim Shettima, Mr Tinubu said Nigeria remained
Previous Story

Boko Haram Terrorists Release Remaining 23 Abuja-Kaduna Train Passengers

Next Story

UCL: Chelsea Manager Potter Expresses Concern On Fofana’s Injury Versus AC Milan

Don't Miss

5 Must-Watch Nollywood Movies And Series This June

5 Must-Watch Nollywood Movies And Series This June

This June, take a break from your usual entertainment and
Africa Must Break Internal Visa Barriers For Shared Prosperity - Editorial

Africa Must Break Internal Visa Barriers For Shared Prosperity – Editorial

Africa - the world's second-largest continent with 54 recognized countries